Пресс релизы

02 июл. 2019

BC Partners to Acquire Synthon International Holding B.V.

read more
05 окт. 2017

Regulatory Approval in Europe granted for Synthon’s glatiramer acetate 40 mg/ml

read more
13 сент. 2017

European Patent Office decides in Synthon’s favor in glatiramer patent case

read more
12 апр. 2016

Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe

read more
03 авг. 2015

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

read more
28 апр. 2015

Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

read more
09 окт. 2014

Synthon Announces Filing of Glatiramer Acetate 40 mg/mL ANDA Containing a Paragraph IV Certification

read more
15 апр. 2014

Synthon obtains European approvals for sevelamer

read more
27 мар. 2014

Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate

read more
24 мая 2012

Synthon obtains European approvals for zoledronic acid

read more
     Share this page